NDC 87450-401-01 - Lidocaine 4% Patch
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 87450-401
- Requested NDC
- 87450-401-01
- Package NDCs from labels
- 87450-401-01, 87450-401-15
- Manufacturer
- Highmark Pharma LLC
- Effective date
- 2026-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine 4% Patch - Highmark Pharma LLC | Highmark Pharma LLC | 2026-10-26 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DYNAMO DELAY | LIDOCAINE | Momentum Management LLC | 2ad63160-4f6f-4970-80b6-f6d19c5660a5 | 2026-10-01 | Warnings | 98PI200987 |
| lidocaine | LIDOCAINE | Glenmark Pharmaceuticals Inc., USA | eaa15be7-11ea-49bc-ac07-739075453be6 | 2026-10-01 | Warnings, Adverse reactions | 98PI200987 |
| Terocin | LIDOCAINE, MENTHOL | Preferred Pharmaceuticals, Inc. | 23843354-e242-4a8a-8818-897592d4d9a0 | 2026-09-30 | Warnings | 98PI200987 |
| BONDLIDO | LIDOCAINE | Terrain Pharmaceuticals, Inc. | 4b206c72-adf2-ba48-e063-6294a90a3840 | 2026-09-30 | Warnings, Adverse reactions | 98PI200987 |
| KONGDY LIDOCAINE KNEE Patch | LIDOCAINE KNEE PATCH | Henan Kangdi Medical Devices Co., Ltd. | 5c9c0d49-fee1-258c-e063-6294a90a3528 | 2026-09-29 | Warnings | 1737778 98PI200987 |
| Lidothol ES | MENTHOL 5%, LIDOCAINE 4% | ASCLEMED USA INC. | 107eed24-d1a5-429e-b388-fad8879e9ca4 | 2026-09-29 | Warnings, Adverse reactions | 98PI200987 |
| Lidocaine | LIDOCAINE | Direct_Rx | 5c8f1543-ef1f-b632-e063-6394a90ace6a | 2026-09-28 | Warnings, Adverse reactions | 98PI200987 |
| Frnxuc Lidocaine patches | LIDOCAINE 4% | Guangzhou Huixue Biotechnology Co., Ltd. | 5c7245cd-80df-02de-e063-6394a90a7eaa | 2026-09-27 | Warnings | 98PI200987 |
| Lidocaine Numbing Cream | LIDOCAINE | Yyba Corp | fe986c22-a30c-4d60-90d0-5d41e0b91958 | 2026-09-25 | Warnings | 98PI200987 |
| Plantar Patch | LIDOCAINE | Active Intelligence, LLC | 5c530b12-5507-adfd-e063-6394a90afb0f | 2026-09-25 | Warnings | 1737778 98PI200987 |
| Lidocaine and prilocaine | LIDOCAINE AND PRILOCAINE | A-S Medication Solutions | f3da2c54-74bb-4186-8cc2-f80e944e12a9 | 2026-09-25 | Warnings, Adverse reactions | 98PI200987 |
| Lidocaine | LIDOCAINE | Par Health USA, LLC | 2ce8a4fe-8aa6-4dc5-ad0f-3984ae68c4bc | 2026-09-25 | Warnings, Adverse reactions | 98PI200987 |
| AIPATCH NUMBING PAIN RELIEF | LIDOCAINE | Active Intelligence, LLC | 56f27540-9b2a-4266-9e15-a5b2d738c7a1 | 2026-09-24 | Warnings | 1737778 98PI200987 |
| CVS Cold and Hot Pain Relief | LIDOCAINE, MENTHOL | CVS Pharmacy | 4a93970c-4ecd-19d5-e063-6394a90ae71c | 2026-09-24 | Warnings | 98PI200987 |
| LIDOCAINE | LIDOCAINE | Preferred Pharmaceuticals Inc. | b693e31d-8b37-4eaa-86c6-09b11ef4d1f4 | 2026-09-24 | Warnings, Adverse reactions | 98PI200987 |
| Lidocaine | BURN RELIEF | Topco Associates LLC | 5faa1d39-12ce-4a65-8e53-0c040e914540 | 2026-09-23 | Warnings | 98PI200987 |
| Qvotic | LIDOCAINE PAIN RELIEF PATCH | Shenzhen Hengdasheng Technology Co., Ltd | 5c0e2414-6a76-4ae2-e063-6294a90a2a10 | 2026-09-22 | Warnings | 98PI200987 |
| Lidocaine Pain-Relieving Patch | LIDOCAINE | CVS Pharmacy | 4ed04089-50be-9e01-e063-6394a90a2b3f | 2026-09-18 | Warnings | 1737778 |
| CVS Pain-Relieving | LIDOCAINE | CVS Pharmacy | 4cd3a3fb-d59c-92a5-e063-6294a90a1737 | 2026-09-17 | Warnings | 1737778 98PI200987 |
| MUYOHON Numbing Cream | NUMBING CREAM | Guangzhou Jingliang Cosmetics Co., Ltd. | 5bb8d107-dbe8-0031-e063-6394a90a4d2e | 2026-09-17 | Warnings | 98PI200987 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.